Tags: acquisitionRemove, chinaRemove, pharmaceuticalsRemove

M&A
Pharmaceutical research company Charles River pays $1.6 billion in cash and stock to acquire Chinese outsourcing company WuXi PharmaTech two-and-a-half years after its listing ...
By Sameera Anand | 27 April 2010
Tag Filters
Polls
What is your outlook on China?


   |   View results
Long-term bullish, I'm buying on the dips
  45%
 
Cautious
  32%
 
Expecting a hard landing
  23%
TOTAL VOTES: 71

 
WEBCASTS
On Demand Webcasts
Magazine
FinanceAsia Magazine
FinanceAsia
May 2012